Angiotensin II up-regulates osteopontin mRNA expression of RAW264.7 macrophages via p38MAPK signaling
Xiaoya Li
Abstract
Xiaoya Li
Abstract
Objective To investigate the changes of osteopontin (OPN) mRNA expression induced by angiotensin Ⅱ (Ang Ⅱ ) in RAW264. 7 macrophages, and to determine the role of p38 mitogen-activated protein kinase(p38MAPK) signaling in up-regulation of OPN mRNA expression. Methods RT-PCR was used for examining the OPN mRNA expression, and the phosphorylation of p38MAPK and activating transcription factor2 (ATF2) was detected by Western blot. Results (1) Ang Ⅱ (1 μmol/L) enhanced the expression of OPN mRNA in RAW264. 7 macrophages with time-dependent, including 0. 9 fold, 2. 3 folds and 2. 4 folds up-regulatoin at 6, 12, 24 h, respectively ( all P 0. 01 ) , whereas there was no significant change in negative control at 0 h and 24 h, suggesting that the mRNA expression of OPN is inducible. (2) Following excitation by Ang Ⅱ in vitro, there was substantial up-regulation of OPN mRNA expression in RAW264. 7 macrophages with dose-dependent; with a dose of 1 μmol/L incubated for 12 h, Ang Ⅱ increased the OPN mRNA expression by 2. 6 folds (P 0. 01). (3) Pre-treatment with SB202190 (5 μmol/L) for 30 min in RAW264. 7 macrophages before Ang Ⅱ (1 μmol/L) used, the expression of OPN mRNA was inhibited by 61.7% (P 0. 01) ; but no marked inhibition had happened at the time of treatment with both SB202190 (5 μmol/L) and Ang Ⅱ (1 μmol/L) added at the same time and with SB202190(5 μmoI/L) for 120 min after AngⅡ (1 μmol/L) used. (4) Pre-treatment with SB202190( 1,5, 10 μmol/L) for 30min in RAW264. 7 macrophages before AngⅡ (1 μmol/L) used, the expression of OPN mRNA was decreased by 43. 4% , 63. 0% 及 65. 5% , respectively ( all P 0. 01 ) . ( 5 ) There was a maximal expression of p38MAPK phosphorylation at 15 - 30 min induced by Ang Ⅱ ( 1 μmol/L) in RAW264. 7 macrophages, and the maximal expression of phosphorylated ATF2 was at 30 - 45 min. (6) Pre-treatment with SB202190 (1,5 μmol/L) for 30 min in RAW264.7 macrophages before Ang Ⅱ (1 μmol/L) used, the expression of p38MAPK phosphorylation was inhibited markedly with dose-dependent, and the phosphorylation of p38MAPK was decreased by 61. 7% (P 0. 01) after the SB202190 (5 μmol/L) was used. Conclusion Angiotensin Ⅱ may up-regulate osteopontin mRNA expression of RAW264. 7 macrophages via p38MAPK signaling.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the changes of osteopontin (OPN) mRNA expression induced by angiotensin Ⅱ (Ang Ⅱ ) in RAW264. 7 macrophages, and to determine the role of p38 mitogen-activated protein kinase(p38MAPK) signaling in up-regulation of OPN mRNA expression. Methods RT-PCR was used for examining the OPN mRNA expression, and the phosphorylation of p38MAPK and activating transcription factor2 (ATF2) was detected by Western blot. Results (1) Ang Ⅱ (1 μmol/L) enhanced the expression of OPN mRNA in RAW264. 7 macrophages with time-dependent, including 0. 9 fold, 2. 3 folds and 2. 4 folds up-regulatoin at 6, 12, 24 h, respectively ( all P 0. 01 ) , whereas there was no significant change in negative control at 0 h and 24 h, suggesting that the mRNA expression of OPN is inducible. (2) Following excitation by Ang Ⅱ in vitro, there was substantial up-regulation of OPN mRNA expression in RAW264. 7 macrophages with dose-dependent; with a dose of 1 μmol/L incubated for 12 h, Ang Ⅱ increased the OPN mRNA expression by 2. 6 folds (P 0. 01). (3) Pre-treatment with SB202190 (5 μmol/L) for 30 min in RAW264. 7 macrophages before Ang Ⅱ (1 μmol/L) used, the expression of OPN mRNA was inhibited by 61.7% (P 0. 01) ; but no marked inhibition had happened at the time of treatment with both SB202190 (5 μmol/L) and Ang Ⅱ (1 μmol/L) added at the same time and with SB202190(5 μmoI/L) for 120 min after AngⅡ (1 μmol/L) used. (4) Pre-treatment with SB202190( 1,5, 10 μmol/L) for 30min in RAW264. 7 macrophages before AngⅡ (1 μmol/L) used, the expression of OPN mRNA was decreased by 43. 4% , 63. 0% 及 65. 5% , respectively ( all P 0. 01 ) . ( 5 ) There was a maximal expression of p38MAPK phosphorylation at 15 - 30 min induced by Ang Ⅱ ( 1 μmol/L) in RAW264. 7 macrophages, and the maximal expression of phosphorylated ATF2 was at 30 - 45 min. (6) Pre-treatment with SB202190 (1,5 μmol/L) for 30 min in RAW264.7 macrophages before Ang Ⅱ (1 μmol/L) used, the expression of p38MAPK phosphorylation was inhibited markedly with dose-dependent, and the phosphorylation of p38MAPK was decreased by 61. 7% (P 0. 01) after the SB202190 (5 μmol/L) was used. Conclusion Angiotensin Ⅱ may up-regulate osteopontin mRNA expression of RAW264. 7 macrophages via p38MAPK signaling.
Key concepts: Osteopontin, Messenger RNA, Angiotensin II, Western blot, p38 mitogen-activated protein kinases, Molecular biology, Downregulation and upregulation, Kinase